Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Prednisolone acetate [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate 25mg/mL injection suspension 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Product containing precisely prednisolone acetate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate 50mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate 25mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate 50mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate 50mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate 25mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate 1.25 mg/mL eye suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate 10 mg/mL eye suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate 1% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Gentamicin sulfate + prednisolone acetate 0.3%/0.6%ww ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Gentamicin sulfate + prednisolone acetate 0.3%/1%vv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate + sulfacetamide sodium 0.2%wv/10%wv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate + sulfacetamide sodium 0.25%wv/10%wv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate + sulfacetamide sodium 5mg/100mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate + sulfacetamide sodium 5mg/100mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Gentamicin sulfate + prednisolone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate + sulfacetamide sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate + sulfacetamide sodium 0.5%ww/10%ww ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Product containing precisely prednisolone 1 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Product containing precisely prednisolone 3 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone 3 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate 50mg/mL injection suspension 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Prednisolone acetate 50mg/mL injection suspension 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
|
Product containing precisely prednisolone acetate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely prednisolone acetate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely prednisolone acetate 25 milligram/1 milliliter conventional release suspension for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely prednisolone acetate 25 milligram/1 milliliter conventional release suspension for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Prednisolone acetate 25 mg/mL suspension for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Prednisolone acetate 25 mg/mL suspension for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Prednisolone acetate 1.25 mg/mL eye suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Prednisolone acetate 1.25 mg/mL eye suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Prednisolone acetate 10 mg/mL eye suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Prednisolone acetate 10 mg/mL eye suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone acetate |
Inferred relationship |
Some |
2 |
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone acetate |
Inferred relationship |
Some |
2 |
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone acetate |
Inferred relationship |
Some |
2 |
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release suspension for eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release suspension for eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely prednisolone (as prednisolone acetate) 5 milligram/1 gram conventional release oromucosal paste (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prednisolone acetate |
Inferred relationship |
Some |
1 |